Introduction:
The FDA’s transition to ESG NextGen is set to take effect soon, requiring all users to adapt to the new system. As part of this upgrade, there will be a submission blackout from April 12th-14th, 2025, during which no electronic submissions will be accepted.
To ensure compliance, PharSafer will hold all submissions during this period, ensuring that any expedited reports due within this timeframe are submitted in advance. Our team has also implemented a structured project plan to manage this transition smoothly, minimising disruption whilst ensuring full compliance.Our Approach Includes:
Key Client Information:
PharSafer is committed to supporting our clients during this transition.
If you have any questions or require further guidance, please contact us directly: enquiries@pharsafer.com 📧
For any questions or to further discuss how PharSafer® can assist with your needs, do not hesitate to contact us or Book a Meeting.